Нормовен

Quick links to important sections

Нормовен

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Нормовен

Property Description
Active ingredient Diosmin and Hesperidin
Form Film-coated tablets (Oral)
Pharmacological class Phlebotonic / Vascular Protecting Agent
General purpose Relieving venous discomfort
Origin Semisynthetic Flavonoid

What Type of Medicine is Нормовен?

Нормовен is a pharmaceutical preparation classified as a venoactive drug and a vascular protecting agent, primarily intended for systemic support. It belongs to the Pharmacological Class of Phlebotonics and Capillary Stabilizers, a category recognized in clinical practice for its ability to improve venous wall function. The core substance, Diosmin, is a compound used for its venotropic and angioprotective properties. The medicine is delivered as a fixed-dose combination product designed for oral (systemic) administration.

Composition: Diosmin, Hesperidin, and Micronization

The distinctive composition of Нормовен hinges on its active ingredients: Diosmin (INN) and Hesperidin, both of which are bioflavonoids of either natural or semisynthetic origin. The final preparation is consistently manufactured as film-coated tablets. A critical feature is the use of micronized active substances, a technique used to significantly enhance the dissolution and improve the overall intestinal bioavailability of the compounds. This high-level feature ensures the components can effectively reach the peripheral vessels for therapeutic action.

General Purpose and Benefit of Phlebotonics

The general purpose of a phlebotonic agent like Нормовен is to provide systemic support by reinforcing the structure of the venous system. By acting as a vascular protecting agent, the medicine is designed to help increase the natural venous tone and reduce the tendency of fluid to leak out of the capillaries. This mechanism directly contributes to the overall benefit of managing the physical symptoms of venous weakness, such as tension, fatigue, and persistent feelings of heaviness in the legs.

What side effects are possible with Нормовен?

Possible Side Effects and Safety Information

The official safety profile for the diosmin and hesperidin combination is structured around adverse reactions categorized by frequency and the organ systems affected, as defined in regulatory documents like the Summary of Product Characteristics (SmPC).

Frequency-Classified Adverse Reactions

The most commonly documented adverse events are associated with Gastrointestinal Disorders. These are classified according to incidence:

Classification Adverse Reactions
Common (1 to 10 users in 100) Diarrhea, Dyspepsia (indigestion), Nausea, Vomiting
Uncommon (1 to 10 users in 1,000) Colitis
Rare (1 to 10 users in 10,000) Dizziness, Headache, Malaise (discomfort), Rash, Pruritus (itching), Urticaria (hives)
Frequency Not Known Abdominal pain, localized Edema (swelling) of the face/lip/eyelid

Serious Adverse Reactions and Safety Constraints

The regulatory documents list Quincke's edema (angioedema), a severe form of allergic swelling, as an exceptional adverse reaction with Frequency Not Known. This represents the most clinically significant hypersensitivity concern.

The medicine is formally contraindicated in individuals with known hypersensitivity to the active substance (micronized purified flavonoid fraction) or to any of the excipients.

Population-Specific Safety Notes

Official labels contain specific notes for certain populations. The use of this combination is not recommended in the pediatric population. For pregnancy, use is generally avoided as a precaution, although animal studies have not indicated reproductive toxicity. For lactation, it is unknown if the active substance is excreted in human milk, meaning a risk to the infant cannot be excluded.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory prescribing information for this medicine, which contains Diosmin and Hesperidin, documents that there is limited experience with overdose cases. The reported events associated with an overdose are primarily a manifestation of adverse symptoms following the ingestion of doses exceeding the recommended administration.

The most frequently reported manifestations listed in official documentation are related to two primary physiological systems. These include gastrointestinal events, specifically documented as abdominal pain, nausea, and diarrhea. Additionally, skin events, such as generalized rash and pruritus (itching), have also been reported in these situations.

Action Trigger Regulator Mandated Instruction
Suspected Overdose Seek medical attention immediately if you experience adverse symptoms after taking more than the recommended dosage.
Dose Exceeded Consult your doctor or pharmacist immediately upon taking an excess dose.

In the event of an overdose, regulatory guidelines state that the management should consist entirely of the treatment of clinical symptoms. No specific antidote is explicitly documented, and therefore, the required procedure involves providing symptomatic and supportive measures. This mandated action ensures appropriate clinical oversight for all reported manifestations.

Therapeutic Uses of Нормовен

What Нормовен Treats: Main Uses and Benefits

Normoven is commonly used to help with managing the disruptive symptom patterns of Chronic Venous Insufficiency (CVI), which typically presents as persistent heaviness, leg pain, and nocturnal cramps. The medication may be applied in clinical settings marked by heightened symptoms associated with hemorrhoidal disease. This ingredient combination is generally used to help relieve symptoms of chronic venous insufficiency. The medication is applied across domains involving certain distressing symptoms in conditions marked by chronic, advanced venous dysfunction, including venous leg ulceration.

“It helps address symptom clusters that may intensify over time, providing support for day-to-day comfort.” This support contributes to easing the overall symptom load during acute hemorrhoidal crises or when dealing with the functional strain of CVI-related swelling. It assists with maintaining functional stability in situations where symptoms may become disruptive, particularly for conditions presenting with disruptive symptom manifestations like persistent venous leg ulceration.


Quick Fact: Relief for Venous Heaviness
Normoven is applied to address the symptoms related to physical discomfort, such as the persistent feeling of heavy legs and fatigue, which interfere with daily functioning.

Regulatory References

  1. Health Canada Product Information

Eligibility and Restrictions for Use

Official Eligibility Profile

The eligibility profile for Нормовен (Diosmin and Hesperidin) is strictly defined by regulatory authorities based on known risks and established clinical data. The medicine is primarily intended for adult use.

Population Status Regulatory Classification
Established Use Adults (18 years and older).
Absolute Prohibition Contraindicated in individuals with a known hypersensitivity or allergy to the active substances or any excipients.

Specific Limitations and Unestablished Use

For certain populations, use is either not recommended or is advised against due to insufficient safety data in regulatory documentation:

  • Pediatric Use: Use in children and adolescents under 18 years of age is not recommended. Safety and efficacy have not been established in this age group.
  • Pregnancy: Use should be avoided as a precautionary measure due to the limited availability of clinical data on pregnant women.
  • Lactation: Use is inadvisable while breastfeeding due to the absence of data regarding whether the active substances pass into human milk.

No explicit restrictions are universally documented as absolute contraindications for patients with kidney or liver impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The formal interaction profile for the Diosmin and Hesperidin combination is defined by the information recorded in governmental regulatory documents concerning the co-administration of the active ingredients. Authorities have consistently concluded that no cases of clinically relevant drug interaction have been reported since the product was marketed. This determination is based on extensive post-marketing experience and surveillance, as opposed to requiring dedicated clinical interaction trials to establish safety boundaries.

Consequently, the regulatory labeling does not contain formal restrictions for co-administration with other medicinal products or pharmacodynamic agents. The official documents specify that there are no mandatory timing rules documented for separating the administration of this medicine from other substances, such as "administer X hours apart." Furthermore, the regulatory guidance on potential interaction with food and drink is formally stated as Not applicable in government-aligned patient information sheets.

The official classification confirms that no specific drug combinations are categorized as contraindicated solely due to a formal interaction risk. Similarly, no specific mechanistic warnings, such as those relating to metabolic enzyme or drug transporter effects, are documented as clinically significant or required for labeling restriction. This regulatory structure indicates that the finished product does not possess an interaction profile that necessitates complex co-administration constraints, according to official regulatory summaries.

Mechanism of Action

Enhancing Venous Tone and Modulating Flow Dynamics

The drug's primary action is the modulation of venous smooth muscle tone. Diosmin achieves this by increasing the local and sustained availability of norepinephrine (NE) at the venous wall, thereby intensifying the activation of boldsymbolalpha-adrenergic receptors. This enhanced noradrenergic signaling leads to the sustained contraction of venous smooth muscle, which directly produces the physiological effect of reducing venous capacity and modulating the velocity of blood flow ( venous return).


Protecting Capillaries and Reducing Filtration

The second, complementary mechanism involves the stabilization of the microvascular barrier. The components inhibit the adhesion and migration of leukocytes to the capillary endothelium, affecting the progression of vascular inflammatory responses. By suppressing the release of damaging mediators like prostaglandins, the drug helps maintain the integrity of the capillary tight junctions. This physiological consequence is a significant reduction in transcapillary filtration (fluid leakage), which influences peripheral fluid exchange dynamics and reduces the formation of interstitial fluid.

Dosage and Administration Information

How to Use Нормовен

Route of Administration and Standard Dosing

Нормовен is administered via the oral route as a film-coated tablet, which is typically manufactured in a 500 mg strength containing the micronized combination of Diosmin and Hesperidin. There are two distinct patterns for administration. For Chronic Venous Insufficiency (CVI), the standard long-term regimen specifies a maintenance dose of two 500 mg tablets daily (1000 mg total MPFF). This daily amount is typically divided into two administrations, often taken midday and evening, to optimize efficacy across the day.

Acute Episodes and Contextual Timing

The protocol for an acute hemorrhoidal attack involves a time-limited, higher-dose schedule to manage the short-term flare-up. Administration begins with a daily dose of six tablets for the first four days, followed by a reduction to four tablets daily for the subsequent three days, thus defining a precise seven-day course. A critical instruction tied to proper use is that the tablets should be taken with meals (at mealtimes). While the CVI dose allows for long-term use over many months, the hemorrhoidal dose is explicitly a short-term, defined course. Administration details are provided for adults, but routine dose adjustments for older adults or individuals with organ impairment are not universally detailed in the primary prescribing documents.

Recent Clinical Evidence

Нормовен: Recent Clinical Evidence

Нормовен is a medication containing a blend of flavonoids, specifically diosmin and hesperidin. This combination is primarily studied for its use in chronic venous disease (CVD) and related symptoms, such as chronic venous insufficiency (CVI) and hemorrhoids.


Chronic Venous Disease and Insufficiency

Clinical trials have investigated the impact of the diosmin and hesperidin combination on the signs and symptoms of CVI. The available research, including randomized controlled studies, suggests that the use of this micronized purified flavonoid fraction (MPFF) is associated with an improvement in certain clinical manifestations of the condition.

  • Symptomatic Relief: Studies have reported that treatment may lead to a reduction in patient-reported symptoms like leg pain, heaviness, and the sensation of swelling in the lower extremities.
  • Objective Measures: Evidence indicates a measurable decrease in lower leg edema and a reduction in the circumference of the ankle and calf in individuals with CVI (CEAP C3). The reduction in edema is often viewed as a key benefit.
  • Advanced Disease: In patients with more advanced stages of CVD, the addition of this flavonoid fraction to standard care (such as compression therapy) has been associated with a faster acceleration of venous leg ulcer healing (CEAP C6) in certain clinical settings.

Hemorrhoids

For hemorrhoidal disease, the combination has been evaluated for its potential role in alleviating both acute and chronic symptoms. The research suggests the MPFF may play a supportive role in symptom management.

Symptom Category Research Observation
Acute Episodes Use has been associated with a reduction in symptoms like pain, bleeding, and edema.
Post-Treatment May be used as an adjunct following surgical procedures to help relieve post-operative symptoms like pain and bleeding.

Safety Profile and Tolerability

Data from clinical trials generally suggest that the combination of diosmin and hesperidin is well-tolerated by most participants when used for the evaluated conditions. The reported frequency of side effects in studies is often described as minimal, comparable to that of a placebo in some cases. Potential side effects may include mild gastrointestinal discomfort, such as diarrhea, nausea, or stomach pain, and on occasion, headaches or dizziness.

Frequently Asked Questions (FAQ)

Common questions about Нормовен (FAQ)

Q: Is Нормовен available without a prescription?

The active ingredients in Нормовен, Diosmin and Hesperidin, are widely available as either a non-prescription medicine or a dietary supplement in many parts of the world. However, the exact availability status (prescription-only or over-the-counter) of the finished product can depend on the specific regulations of the country where it is purchased.


Q: Is Нормовен used to treat varicose veins or just symptoms?

According to official product information, this medicine is recommended for managing the signs and symptoms associated with venous circulation disorders, which include conditions that cause varicose veins. Its intended use is focused on providing relief from symptoms like pain, heavy legs, and swelling related to chronic venous disease, rather than reversing the underlying physical cause of the disease.


Q: Are there any long-term safety concerns described for Нормовен?

Clinical studies have examined the long-term use of the active ingredients, often for periods up to one year. Official data indicates the drug is generally well-tolerated during this time. No statistically significant changes have been observed in key laboratory tests, such as those related to liver or kidney function.


Q: Does taking Нормовен affect blood pressure?

Some clinical trials evaluating long-term safety of the active ingredient have reported that the therapy did not significantly affect the values of systolic or diastolic blood pressure. The drug’s main effects are concentrated on the venous system rather than the arterial system.


Q: How long does it typically take to notice the effects of Нормовен?

Evidence from studies on chronic venous insufficiency suggests that patients may begin to notice an improvement in symptoms relatively quickly. Patient-reported relief, such as a decrease in the sensation of heavy legs, is sometimes observed within the first couple of months of administration.


Q: What happens if I forget to take Нормовен for a day?

Regulatory patient information outlines a standard protocol for missed doses. This protocol describes that if a dose is forgotten, it is generally to be taken as soon as it is remembered, unless it is nearly time for the next dose. If so, the regular schedule is followed, and the forgotten dose is not doubled.


Q: Is Нормовен appropriate for older adults (over 65)?

The medicine is indicated for use in all adults, starting at 18 years and older. While older adults are included in the established use population, regulatory documents do not universally detail specific, routine dose adjustments for those over the age of 65.


Q: What is the mechanism of action for the ingredients in Нормовен, in simple terms?

In simple terms, the medicine is classified as a venotonic and a vasculoprotector. This means it works by increasing the tone and strength of the veins while also increasing the resistance of small blood vessels (capillaries). This action helps improve blood flow and reduces fluid leakage into surrounding tissue.


Q: Why is proper storage important for maintaining the effectiveness of Нормовен?

Official storage instructions are necessary to maintain the product’s quality and integrity. Storing the medicine according to the required temperature and packaging instructions helps ensure that the active substances remain chemically stable and effective throughout their designated shelf life.


Q: What should I do if I suspect an allergic reaction to Нормовен?

Official safety guidance outlines the protocol for severe allergic reactions (e.g., swelling of the face, lips, or eyelids, known as Quincke's edema). This protocol describes that the use of the medicine is discontinued, and professional medical assistance is sought immediately.


Q: Does Нормовен have any known effect on liver function?

The official safety profile and long-term clinical trials have generally reported no signs of toxic effects or impairment on typical liver function tests. Information does exist regarding specific regulatory warnings that may apply to individuals with pre-existing severe liver conditions.


Q: What are the signs that Нормовен may not be working for me?

Official regulatory labels include statements regarding a lack of symptom improvement or worsening of symptoms during treatment. For example, the label notes that patients should contact a healthcare provider if acute hemorrhoidal symptoms persist beyond 15 days.


Q: Can I use Нормовен if I have an existing heart condition?

The official product information does not list having a heart condition as an absolute contraindication for use. Clinical studies sometimes indicate that individuals with severe pre-existing heart conditions may be excluded from participation.


Q: What is the purpose of the core section titled 'Interactions with other medicines and products'?

The regulatory purpose of this section is to inform the patient that, based on extensive post-marketing surveillance and evaluation, no cases of clinically relevant drug interactions have been reported. This confirms that the drug's profile does not necessitate complex rules for co-administering it with other substances.


Q: What does 'contraindication' mean in the context of using Нормовен?

In regulatory language, a contraindication means that the drug should absolutely not be used by certain people because the risks clearly outweigh any potential benefits. For Нормовен, the key contraindication is a known hypersensitivity or allergy to the active ingredients or excipients.


Q: Is it safe to drive or operate machinery while taking Нормовен?

Official regulatory labels state that the medicine does not typically affect a patient's ability to drive or operate machinery. However, because rare side effects like dizziness and headache are reported, regulatory guidance indicates that activities requiring focus are to be avoided if those specific side effects occur.


Q: Does Нормовен cause drowsiness?

Drowsiness, also known as somnolence, is not listed as a common, uncommon, or rare side effect in the official safety profile. The nervous system adverse reactions that are documented as rare include headache and dizziness.


Q: Is it necessary to make lifestyle changes while taking Нормовен?

Official regulatory information for venous circulation disorders suggests that the treatment is most effective when used alongside a healthy lifestyle. This includes avoiding prolonged standing or exposure to heat and promoting circulation through actions like walking or wearing compression stockings.


Q: Why is it important to check the section 'Who can and cannot use Нормовен'?

Checking this section is essential because it defines the absolute prohibition for use, which is a known hypersensitivity or allergy. It also lists specific populations (such as pregnant women, breastfeeding women, and children) for whom the medicine is not recommended due to a lack of complete safety data.

How should Нормовен be stored and disposed of?

How to Store and Dispose of Normoven

This section outlines the official, regulatory requirements for storing and discarding Normoven (Diosmin and Hesperidin) film-coated tablets.

Storage Requirement Official Condition
Temperature Store below 30°C (Do not expose to excessive heat).
Packaging Must be kept in the original carton to maintain product integrity.
Shelf Life Stability is maintained for 3 years when stored according to conditions.
Accessibility Keep out of the sight and reach of children.

Disposal Instructions

Normoven is not classified as hazardous medical waste. Unused or expired tablets should be disposed of following standard local or national procedures for non-hazardous medicinal products. There are no special handling or environmental protection rules required for disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Нормовен found in:

A-Z Index: